Alvimopan 12mgCapsule
Gastrointestinal

Alvimopan 12mg

Alvimopan

Peripherally acting mu-opioid receptor antagonist for accelerating GI recovery after bowel surgery. Manufactured by Indian pharmaceutical companies for hospital export.

Strengths

12mg

Packing

30 capsules/bottle

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Alvimopan 12mg
Dosage Form
Capsule
Available Strengths
12mg
Packing
30 capsules/bottle
Route of Administration
Oral
Dosage
12mg given 30 minutes to 5 hours before surgery; then 12mg twice daily starting day after surgery for max 7 days (max 15 doses)
Indications
Acceleration of upper and lower GI recovery following partial large or small bowel resection with primary anastomosis
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 25°C
Shelf Life
36 months
Side Effects
Dyspepsia, hypokalemia, back pain, urinary retention, anemia, flatulence
Precautions
Hospital-use only (REMS program); max 15 doses; avoid in complete bowel obstruction; not for patients on chronic opioid therapy (>7 consecutive days)

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Alvimopan 12mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote